This educational activity presents information on the mechanism of action of the new nonsteroidal agents, evidence from their premarketing clinical trials, and expert insights on their use in clinical practice.

This case-based educational activity focuses on reinforcing the role of nitric oxide (NO) in glaucomatous eyes; achieving target intraocular pressure (IOP) levels; targeting new sites of action, such as the trabecular meshwork, with emerging therapies; and interpreting clinically relevant data supporting a role for emerging medical therapies in patients with glaucoma.

This educational activity aims to help clinicians recognize epidemiologic factors that influence geographic atrophy (GA), identify key findings on imaging throughout the course of GA, and understand the pathophysiology of GA in the context of new and emerging treatments.

This educational activity aims to educate ophthalmologists on the epidemiology and underlying pathophysiology of meibomian gland dysfunction, diagnostic techniques, and current and emerging treatments.